{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:24:15Z","timestamp":1781090655923,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.biologicals.2010.05.001","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T00:49:28Z","timestamp":1277081368000},"page":"552-556","source":"Crossref","is-referenced-by-count":15,"title":["Ulinastatin-mediated protection against zymosan-induced multiple organ dysfunction in rats"],"prefix":"10.1016","volume":"38","author":[{"given":"Qiuping","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2010.05.001_bib1","series-title":"Surgical Treatment: Evidence-based and problem-oriented","first-page":"780","article-title":"The multiple organ dysfunction syndrome","author":"Marshall","year":"2001"},{"key":"10.1016\/j.biologicals.2010.05.001_bib2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ccm.2008.06.011","article-title":"Reducing mortality in severe sepsis: the Surviving Sepsis Campaign","volume":"29","author":"Townsend","year":"2008","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.biologicals.2010.05.001_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1478-5153.2008.00289.x","article-title":"Multiple organ dysfunction syndrome pathogenesis and care: a complex systems' theory perspective","volume":"13","author":"Papathanassoglou","year":"2008","journal-title":"Nurs Crit Care"},{"key":"10.1016\/j.biologicals.2010.05.001_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.disamonth.2009.04.002","article-title":"The multiple organ dysfunction syndrome","volume":"55","author":"Mizock","year":"2009","journal-title":"Dis Mon"},{"key":"10.1016\/j.biologicals.2010.05.001_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0006-2944(82)90008-4","article-title":"The major urinary protease inhibitor: simplified purification and characterization","volume":"27","author":"Bromke","year":"1982","journal-title":"Biochem Med"},{"key":"10.1016\/j.biologicals.2010.05.001_bib6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1248\/bpb.21.651","article-title":"Human neutrophil elastase degrades inter-alpha-trypsin inhibitor to liberate urinary trypsin inhibitor related proteins","volume":"21","author":"Hirose","year":"1998","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.biologicals.2010.05.001_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.transproceed.2008.01.034","article-title":"Ulinastatin is a novel protease inhibitor and neutral protease activator","volume":"40","author":"Umeadi","year":"2008","journal-title":"Transpl Proc"},{"key":"10.1016\/j.biologicals.2010.05.001_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/CCLM.2005.001","article-title":"Pathophysiology and diagnostic value of urinary trypsin inhibitors","volume":"43","author":"Pugia","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.biologicals.2010.05.001_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1542-3565(04)00671-8","article-title":"Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial","volume":"3","author":"Tsujino","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.biologicals.2010.05.001_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1443-9573.2002.00074_3_2.x","volume":"2","author":"Chen","year":"2002","journal-title":"Chin J Digestion"},{"key":"10.1016\/j.biologicals.2010.05.001_bib11","first-page":"883","article-title":"Treatment of patients with severe sepsis using ulinastatin and thymosin alpha1: a prospective, randomized, controlled pilot study","volume":"122","author":"Chen","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.biologicals.2010.05.001_bib12","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1016\/S0041-1345(98)01214-7","article-title":"Ulinastatin, a protease inhibitor, attenuates hepatic ischemia\/reperfusion injury by downregulating TNF-alpha in the liver","volume":"30","author":"Aihara","year":"1998","journal-title":"Transpl Proc"},{"key":"10.1016\/j.biologicals.2010.05.001_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/jsre.1998.5496","article-title":"Protective effects of ulinastatin against ischemia-reperfusion injury","volume":"82","author":"Okuhama","year":"1999","journal-title":"J Surg Res"},{"key":"10.1016\/j.biologicals.2010.05.001_bib14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.burns.2007.08.024","article-title":"Prospective clinical and experimental studies on the cardioprotective effect of ulinastatin following severe burns","volume":"34","author":"Huang","year":"2008","journal-title":"Burns"},{"key":"10.1016\/j.biologicals.2010.05.001_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2079","article-title":"The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling","volume":"7","author":"O\u2019Neill","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biologicals.2010.05.001_bib16","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","article-title":"Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product","volume":"162","author":"Hoshino","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.biologicals.2010.05.001_bib17","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.2174\/138161208784980572","article-title":"Sepsis: links between pathogen sensing and organ damage","volume":"14","author":"Crouser","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biologicals.2010.05.001_bib18","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1097\/01.CCM.0000069343.27691.F3","article-title":"Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality","volume":"31","author":"Williams","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.biologicals.2010.05.001_bib19","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archsurg.2009.211","article-title":"Clinical relevance of the TLR4 11367 polymorphism in patients with major trauma","volume":"144","author":"Duan","year":"2009","journal-title":"Arch Surg"},{"key":"10.1016\/j.biologicals.2010.05.001_bib20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/jmg.2004.021600","article-title":"TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury","volume":"41","author":"Barber","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.biologicals.2010.05.001_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jpedsurg.2004.11.042","article-title":"Altered chemokine response in an animal model of multiple organ dysfunction syndrome induced by zymosan","volume":"40","author":"Thomas","year":"2005","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.biologicals.2010.05.001_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1590\/S0102-86502004000200001","article-title":"Experimental models of sepsis and septic shock: an overview","volume":"19","author":"Garrido","year":"2004","journal-title":"Acta Cirurgica Brasileira"},{"key":"10.1016\/j.biologicals.2010.05.001_bib23","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/CCM.0b013e3181922bd3","article-title":"Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting?","volume":"37","author":"Dyson","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.biologicals.2010.05.001_bib24","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/339549","article-title":"Clinical trials of immunomodulatory therapies in severe sepsis and septic shock","volume":"34","author":"Vincent","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2010.05.001_bib25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2010.05.001_bib26","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00134-008-1266-6","article-title":"Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock","volume":"34","author":"Finfer","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.biologicals.2010.05.001_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1034\/j.1399-6576.2001.045003364.x","article-title":"Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course","volume":"45","author":"Spielmann","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.biologicals.2010.05.001_bib28","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.4049\/jimmunol.143.4.1278","article-title":"The effect of anti-intercellular adhesion molecule-1 on phorbol-ester-induced rabbit lung inflammation","volume":"143","author":"Barton","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.biologicals.2010.05.001_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1757-7241-17-49","article-title":"IL-6 predicts organ dysfunction and mortality in patients with multiple injuries","volume":"17","author":"Frink","year":"2009","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"10.1016\/j.biologicals.2010.05.001_bib30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005373-199407000-00017","article-title":"Elevated levels of soluble ICAM-1 correlate with the development of multiple organ failure in severely injured trauma patients","volume":"37","author":"Law","year":"1994","journal-title":"J Trauma"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105610001132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105610001132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T18:07:20Z","timestamp":1711562840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105610001132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1045105610001132"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2010.05.001","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}